Company Ticker News August 1, 2021Can Merck Beat Pfizer in This Multibillion-Dollar Vaccine Market? 0 0 Share
Company Ticker News July 29, 2021Merck Sales Beat Estimates, But the Stock Fell. Here's 1 Reason to Be Bullish. 0 0 Share
Press Release July 27, 2021Merck's Keytruda Combo Trial Meets Overall Survival Endpoint In PD-L1 Expressing Breast Cancer Patients 0 0 Share
Press Release July 17, 2021Merck Announces U.S. FDA Approval of VAXNEUVANCE™ (Pneumococcal 15-valent Conjugate Vaccine) for the Prevention of Invasive Pneumococcal Disease in Adults 18 Years and Older Caused by 15 Serotypes 0 0 Share
Press Release July 16, 2021Merck Touts Encouraging Event-Free Survival For Keytruda Regime Over Placebo-Chemo Regime In Breast Cancer 0 0 Share
Company Ticker News July 12, 2021Barron's 100 Top ESG Equities Show 77 With Dividends And 2 With Ideal Returns 0 0 Share
